Paxilitaxel induces apoptosis accompanied by protective autophagy in osteosarcoma cells through hypoxia-inducible factor-1α pathway
- PMID:26017247
- DOI: 10.3892/mmr.2015.3860
Paxilitaxel induces apoptosis accompanied by protective autophagy in osteosarcoma cells through hypoxia-inducible factor-1α pathway
Abstract
Paxilitaxel, a drug used in cancer chemoprevention and treatment, has shown promising anti‑cancer effects against a broad spectrum of tumors. However, the effect of paxilitaxel on osteoblasts has remained to be elucidated. The aim of the present study was to investigate the anti‑tumor effect of paxilitaxel on human osteosarcoma cancer cells, the underlying molecular mechanism as well as drug resistance involved. The results showed that paxilitaxel not only induced apoptosis via the mitochondrial pathway but also induced autophagy, which partially inhibited cell apoptosis. The present study also demonstrated that paxilitaxel induced autophagy through the hypoxia‑inducible factor (HIF)‑1α pathway. Moreover, paxilitaxel‑induced apoptosis decreased following incubation with with the autophagy inducer rapamycin. By contrast, co‑treatment with the HIF‑1α inhibitor YC‑1 or autophagy inhibitor 3‑methyladenine significantly blocked autophagy and augmented the anti‑tumor effects of paxilitaxel. Therefore, the results of the present study suggested that the combination of paxilitaxel with an autophagy inhibitor or a HIF‑1α inhibitor may be an effective and potent strategy for improved chemotherapy of osteosarcoma in the future.
Similar articles
- Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells.Kim HJ, Lee SG, Kim YJ, Park JE, Lee KY, Yoo YH, Kim JM.Kim HJ, et al.Int J Oncol. 2013 Jun;42(6):1985-92. doi: 10.3892/ijo.2013.1884. Epub 2013 Apr 5.Int J Oncol. 2013.PMID:23563171
- X609, a novel manassantin A derivative, exhibits antitumor activity in MG-63 human osteosarcoma cells in vitro and in vivo.Li J, Zhao K, Wang F, Cai J, Li Z, Zou L.Li J, et al.Mol Med Rep. 2015 Aug;12(2):3115-20. doi: 10.3892/mmr.2015.3729. Epub 2015 May 5.Mol Med Rep. 2015.PMID:25954853
- CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma.Wang Z, Yin F, Xu J, Zhang T, Wang G, Mao M, Wang Z, Sun W, Han J, Yang M, Jiang Y, Hua Y, Cai Z.Wang Z, et al.J Exp Clin Cancer Res. 2019 Jan 31;38(1):44. doi: 10.1186/s13046-019-1047-9.J Exp Clin Cancer Res. 2019.PMID:30704503Free PMC article.
- Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment.Li J, Yang Z, Li Y, Xia J, Li D, Li H, Ren M, Liao Y, Yu S, Chen Y, Yang Y, Zhang Y.Li J, et al.Oncotarget. 2016 Jul 12;7(28):44763-44778. doi: 10.18632/oncotarget.8206.Oncotarget. 2016.PMID:27007056Free PMC article.Review.
- Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.Rohwer N, Cramer T.Rohwer N, et al.Drug Resist Updat. 2011 Jun;14(3):191-201. doi: 10.1016/j.drup.2011.03.001. Epub 2011 Apr 3.Drug Resist Updat. 2011.PMID:21466972Review.
Cited by
- Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality.Yu L, Zhang J, Li Y.Yu L, et al.Front Immunol. 2022 Oct 13;13:871076. doi: 10.3389/fimmu.2022.871076. eCollection 2022.Front Immunol. 2022.PMID:36311748Free PMC article.Review.
- Inhibition of autophagy results in a reversal of taxol resistance in nasopharyngeal carcinoma by enhancing taxol-induced caspase-dependent apoptosis.Song Y, Li W, Peng X, Xie J, Li H, Tan G.Song Y, et al.Am J Transl Res. 2017 Apr 15;9(4):1934-1942. eCollection 2017.Am J Transl Res. 2017.PMID:28469798Free PMC article.
- Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication.Niu J, Yan T, Guo W, Wang W, Zhao Z.Niu J, et al.Front Oncol. 2019 Nov 15;9:1232. doi: 10.3389/fonc.2019.01232. eCollection 2019.Front Oncol. 2019.PMID:31803616Free PMC article.Review.
- Role of autophagy in drug resistance and regulation of osteosarcoma (Review).Pu Y, Wang J, Wang S.Pu Y, et al.Mol Clin Oncol. 2022 Mar;16(3):72. doi: 10.3892/mco.2022.2505. Epub 2022 Feb 1.Mol Clin Oncol. 2022.PMID:35251623Free PMC article.Review.
- New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer.An J, Peng C, Tang H, Liu X, Peng F.An J, et al.Int J Mol Sci. 2021 Sep 6;22(17):9644. doi: 10.3390/ijms22179644.Int J Mol Sci. 2021.PMID:34502549Free PMC article.Review.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical